Skip to main content

Advertisement

Log in

Varizellen in der Schwangerschaft und bei Neugeborenen

Varicella during pregnancy and in neonates

  • Originalien und Übersichtsarbeiten
  • Published:
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz Aims and scope

Zusammenfassung

Varizellen (Windpocken) gehören zu den häufigsten impfpräventablen Erkrankungen in Deutschland. Während der Schwangerschaft kann die Erkrankung zu schweren Folgen für die Schwangere selbst sowie für den Fetus bzw. das Neugeborene führen. Für schwangere Frauen ist das Risiko für eine Varizellenpneumonie, die als medizinischer Notfall anzusehen ist, erhöht. Zwischen der 5. und 24. Schwangerschaftswoche können Windpocken zum fetalen Varizellensyndrom führen. Bei einer mütterlichen Erkrankung in den letzten Schwangerschaftswochen oder kurz nach der Entbindung kann der Erreger Varizellen des Neugeborenen hervorrufen. Geschieht dies in einem Zeitraum von 5 Tagen vor bis zu 2 Tagen nach der Geburt, ist mit lebensbedrohlichen disseminierten neonatalen Varizellen zu rechnen. Mit den derzeit zur Verfügung stehenden diagnostischen, immunprophylaktischen und therapeutischen Maßnahmen besteht die Möglichkeit, diese schwerwiegenden Folgen von Varizellen während der Gravidität zu verhindern.

Abstract

Varicella belongs to the most common vaccine-preventable diseases in Germany. During pregnancy, varicella may have serious consequences for the pregnant women and for the fetus or newborn. Pregnant women who contract varicella are at risk of pneumonia which must be regarded as a medical emergency. Chicken pox between the 5th and 24th weeks of pregnancy may lead to the congenital varicella syndrome. In case of maternal varicella during the last few weeks of pregnancy or shortly after delivery, the virus can cause chicken pox in the newborn. Life-threaten ing disseminated neonatal varicella must be expected if the mother develops chicken pox between 5 days before and 2 days after delivery. Using currently available diagnostics, immuno-prophylactic and therapeutic opportunities, these serious consequences of varicella during pregnancy can be prevented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Wutzler P, Färber I, Wagenpfeil S et al. (2001) Seroprevalence of varicella-zoster virus in the German population. Vaccine 20:121–124

    Article  PubMed  CAS  Google Scholar 

  2. Robert Koch-Institut (2003) Zur Seroprävalenz gegen Varicella-Zoster-Virus und zur Verlässlichkeit anamnestischer Angaben. Epidemiol Bull 43:347

    Google Scholar 

  3. Stagno S, Whitley RJ (1985) Herpesvirus infections of pregnancy. Part II:Herpes simplex virus and varicella- zoster virus infections. N Engl J Med 313:1327–1330

    Article  PubMed  CAS  Google Scholar 

  4. Enders G, Miller E (2000) Varicella and herpes zoster in pregnancy and the newborn. In:Arvin AM, Gershon AA (eds) Varicella-zoster virus. Virology and clinical management. University Press, Cambridge, pp 317–347

  5. Smego RA Jr, Asperille MO (1991) Use of acyclovir for varicella pneumonia during pregnancy. Obstet Gynecol 78:1112–1116

    PubMed  Google Scholar 

  6. Enders G, Miller E, Cradock-Watson J et al. (1994) Consequences of varicella and herpes zoster in pregnancy:prospective study of 1739 cases. Lancet 343:1548–1551

    Article  PubMed  CAS  Google Scholar 

  7. Liesnard C, Donner C, Brancart F, Rodesch F (1994) Varicella in pregnancy. Lancet 344:350–351

    Article  Google Scholar 

  8. Paryani SG, Arvin AM (1986) Intrauterine infection with varicella-zoster virus after maternal varicella. N Engl J Med 314:1542–1546

    Article  PubMed  CAS  Google Scholar 

  9. Prober CG, Gershon AA, Grose C et al. (1990) Consensus:varicella-zoster infections in pregnancy and the perinatal period. Pediatr Infect Dis J 9:865–869

    Article  PubMed  CAS  Google Scholar 

  10. Pastuszak AL, Levy M, Schick B et al. (1994) Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med 330:901–905

    Article  PubMed  CAS  Google Scholar 

  11. Sauerbrei A, Wutzler P (2001) Neonatal varicella. J Perinatol 21:545–549

    Article  PubMed  CAS  Google Scholar 

  12. Sauerbrei A, Wutzler P (2003) Das fetale Varizellensyndrom. Monatsschr Kinderheilkd 151:209–213

    Article  Google Scholar 

  13. Sauerbrei A, Wutzler P (2000) The congenital varicella syndrome. J Perinatol 20:548–554

    Article  PubMed  CAS  Google Scholar 

  14. Miller E, Cradock-Watson JE, Ridehalgh MK (1989) Outcome in newborn babies given anti-varicellazoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet 2:371–373

    Article  PubMed  CAS  Google Scholar 

  15. Harris RE, Rhoades ER (1965) Varicella pneumonia complicating pregnancy. Report of a case and review of literature. Obstet Gynecol 25:734–740

    PubMed  CAS  Google Scholar 

  16. Harger JH, Ernest JM, Thurnau GR et al., National Institute of Child Health and Human Development, Network of Maternal-Fetal Medicine Units (2002) Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. J Infect Dis 185:422–427

    Article  PubMed  Google Scholar 

  17. Haake DA, Zakowski PC, Haake DL, Bryson XJ (1990) Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults:retrospective controlled study and review. Rev Infect Dis 12:788–798

    PubMed  CAS  Google Scholar 

  18. Chandra PC, Patel H, Schiavello HJ, Briggs SL (1998) Successful pregnancy outcome after complicated varicella pneumonia. Obstet Gynecol 92:680–682

    Article  PubMed  CAS  Google Scholar 

  19. Laforet EG, Lynch CJ Jr (1947) Multiple congenital defects following maternal varicella. N Engl J Med 236:534–537

    Article  CAS  PubMed  Google Scholar 

  20. Sauerbrei A, Wutzler P (2005) Varicella-zoster virus infections during pregnancy:epidemiology, clinical symptoms, diagnosis, prevention and therapy. Curr Pediat Rev 1:205–216

    Article  Google Scholar 

  21. Robert Koch-Institut (2006) Zur Sentinel-Surveillance der Varizellen in Deutschland. Epidemiol Bull 36:307–309

    Google Scholar 

  22. Grose C (1989) Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity. Mol Biol Med 6:453–462

    PubMed  CAS  Google Scholar 

  23. Higa K, Dan K, Manabe H (1987) Varicella-zoster virus infections during pregnancy:Hypothesis concerning the mechanisms of congenital malformation. Obstet Gynecol 69:214–221

    PubMed  CAS  Google Scholar 

  24. Schulze A, Dietzsch HJ (2000) The natural history of varicella embryopathy:a 25-year follow-up. J Pediatr 137:871–874

    Article  PubMed  CAS  Google Scholar 

  25. Heidl M (1985) Varicella-Zoster-Virus-Infektion in der Schwangerschaft, beim Neugeborenen und jungen Säugling. Z Klin Med 40:245–250

    Google Scholar 

  26. Hubbard TW (1878) Varicella occurring in an infant twenty four hours after birth. Br Med J 1:822

    Google Scholar 

  27. Hanngren K, Grandien M, Granström G (1985) Effect of zoster immunoglobulin for varicella prophylaxis in the newborn. Scand J Infect Dis 17:343–347

    PubMed  CAS  Google Scholar 

  28. Meyers JD (1974) Congenital varicella in term infants:risk reconsidered. J Infect Dis 129:215–217

    PubMed  CAS  Google Scholar 

  29. Baba K, Yabuuchi H, Takahashi M, Ogra PL (1982) Immunologic and epidemiologic aspects of varicella infection acqired during infancy and early childhood. J Pediatr 100:881–885

    Article  PubMed  CAS  Google Scholar 

  30. Deutsche Gesellschaft für Pädiatrische Infektiologie (2003) Handbuch:Infektionen im Kindesalter, 4. Aufl. Futuramed, München, S 732–739

  31. Akisu M, Yalaz M, Aksu G et al. (2003) Maternally acquired varicella-zoster virus antibodies disappear at 6 months of age in prematurely born children. Panminerva Med 45:155–156

    PubMed  CAS  Google Scholar 

  32. Gershon AA, Raker R, Steinberg S et al. (1976) Antibody to varicella-zoster virus in parturient women and their offspring during the first year of life. Pediatrics 58:692–696

    PubMed  CAS  Google Scholar 

  33. Koskimies O, Lapinleimu K, Saxén L (1978) Infections and other maternal factors as risk indicators for congenital malformations:a case-control study with paired serum samples. Pediatrics 61:832–837

    PubMed  CAS  Google Scholar 

  34. Johansson AB, Rassart A, Blum D et al. (2004) Lower-limb hypoplasia due to intrauterine infection with herpes simplex virus type 2:possible confusion with intrauterine varicellazoster syndrome. Clin Infect Dis 38:e57–62

    Article  PubMed  Google Scholar 

  35. Sauerbrei A, Glück B, Jung K et al. (2000) Congenital skin lesions caused by intrauterine coxsackievirus B3 infection:a case report. Infection 28:326–328

    Article  PubMed  CAS  Google Scholar 

  36. Spranger S, Stute H, Blankenagel A et al. (1998) MIDAS-Syndrom – Eine X-chromosomale Erkrankung. Differenzialdiagnose zum kongenitalen Varizellensyndrom. Monatsschr Kinderheilkd 146:761–765

    Article  Google Scholar 

  37. Gershon AA (1998) Varicella-zoster virus. In:Feigin RD, Cherry JD (eds) Textbook of pediatric infectious diseases, 4th edn. W.B. Saunders, Philadelphia, S 1769–1777

  38. Ständige Impfkommission am Robert Koch- Institut (2006) Empfehlungen der Ständigen Impfkommission am Robert Koch-Institut/Stand:Juli 2006. Epidemiol Bull 30:235–254

    Google Scholar 

  39. Salzman MB, Sharrar RG, Steinberg S, LaRussa P (1997) Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother. J Pediatr 131:151–154

    Article  PubMed  CAS  Google Scholar 

  40. Shields KE, Galil K, Seward J et al. (2001) Varicella vaccine exposure during pregnancy:data from the first 5 years of the pregnancy registry. Obstet Gynecol 98:14–19

    Article  PubMed  CAS  Google Scholar 

  41. Robert Koch-Institut (2005) Neuerungen in den aktuellen Impfempfehlungen der STIKO. Epidemiol Bull 31:273–276

    Google Scholar 

  42. Ogilvie NM (1998) Antiviral prophylaxis and treatment in chickenpox. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect 36 [Suppl 1]:31–38

    Article  PubMed  Google Scholar 

  43. Andrews EB (1994) Acyclovir does not increase risk in pregnancy. Am Pharm NS 34:6

    Google Scholar 

  44. Verstraelen H, Vanzieleghem B, Deroort P et al. (2003) Prenatal ultrasound and magnetic resonance imaging in fetal varicella syndrome:correlation with pathology findings. Prenat Diagn 23:705–709

    Article  PubMed  Google Scholar 

  45. Pretorius DH, Hayward I, Jones KL, Stamm E (1992) Sonographic evaluation of pregnancies with maternal varicella infection. J Ultrasound Med 11:459–463

    PubMed  CAS  Google Scholar 

  46. Sauerbrei A, Pawlak J, Luger C, Wutzler P (2003) Intracerebral VZV reactivation in congenital varicella syndrome? A case report. Dev Med Child Neurol 45:837–840

    Article  PubMed  CAS  Google Scholar 

  47. Paulman PM, McLellan R (1990) Varicella during pregnancy:the timing of effective treatment. J Am Board Fam Pract 3:121–123

    PubMed  CAS  Google Scholar 

  48. Zieger W, Friese K, Weigel M et al. (1994) Varizellen- Infektion am Geburtstermin. Z Geburtshilfe Perinatol 198:134–137

    PubMed  CAS  Google Scholar 

  49. Carter PE, Duffty P, Lloyd DJ (1986) Neonatal varicella infection. Lancet 2:1459–1460

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter Wutzler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wutzler, P., Sauerbrei, A. Varizellen in der Schwangerschaft und bei Neugeborenen. Bundesgesundheitsbl. 50, 237–244 (2007). https://doi.org/10.1007/s00103-007-0143-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00103-007-0143-8

Schlüsselwörter

Keywords

Navigation